Skip to main content
quantum.org.uk home

Search

    Completed Consortium

    QuPharma: Quantum Enhanced Computing Platform for Pharmaceutical R&D

    A SEEQC-led consortium linking a quantum computer with a classical supercomputer to model drug properties.

    Project data last updated 11 October 2026

    About this project

    QuPharma ran from March 2022 to March 2025. Merck was the end user. STFC's Hartree Centre, its Scientific Computing Department and the National Quantum Computing Centre took part.

    The stated aim was to speed up parts of drug development by a factor of ten. The first focus was simulation tools for photodynamic cancer therapies.

    Lead organisation

    SEEQC UK

    Company · London

    UK arm of SEEQC, maker of superconducting digital control chips for qubits, which led the QuPharma drug-discovery quantum computing project.

    Partners (6)

    Funders

    In the news

    Quantum Zeitgeist articles naming the lead organisation or partners. They may not be about this project.

    All news for this project and its partners

    Sources

    1. Gateway to Research: Quantum Enhanced Computing Platform for Pharmaceutical R&D - QuPharma (gtr.ukri.org)
    2. STFC Hartree Centre: £50m funding for UK quantum computing projects with industry (hartree.stfc.ac.uk)